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Cell surface receptors and secreted proteins play important roles in neural recognition processes, but
because their site of action can be a long distance from neuron cell bodies, antibodies that label these
proteins are valuable to understand their function. The zebraﬁsh embryo is a popular vertebrate model
for neurobiology, but suffers from a paucity of validated antibody reagents. Here, we use the entire
ectodomain of neural zebraﬁsh cell surface or secreted proteins expressed in mammalian cells to select
monoclonal antibodies to ten different antigens. The antibodies were characterised by Western blotting
and the sensitivity of their epitopes to formalin ﬁxation was determined. The rearranged antigen binding
regions of the antibodies were ampliﬁed and cloned which enabled expression in a recombinant form
from a single plasmid. All ten antibodies gave speciﬁc staining patterns within formalin-treated
embryonic zebraﬁsh brains, demonstrating that this generalised approach is particularly efﬁcient to elicit
antibodies that stain native antigen in ﬁxed wholemount tissue. Finally, we show that additional tags can
be easily added to the recombinant antibodies for convenient multiplex staining. The antibodies and the
approaches described here will help to address the lack of well-deﬁned antibody reagents in zebraﬁsh
research.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
The intercellular connectivity of neurons is critical for correct
function, but detailed descriptions of neuronal wiring circuits in
vertebrates are still lacking, and their functional outputs poorly
understood [1]. Mapping neuronal networks is a challenging task
because vast numbers of neurons are densely packed within the
central nervous system, and their many processes often connect
to neurons at anatomically distant sites [2]. Mechanistically, the
development of neuronal networks is regulated by a series of
attractive and repulsive cues mediated by factors that are secreted
by, and displayed on the surface of cells within the nervous system[3]. The expression of these guidance molecules is highly regulated
and identifying when and where they are expressed is important to
obtain a molecular understanding of neuronal network develop-
ment and function. While important progress has been made on
the large scale documentation of gene expression patterns within
the nervous system, the technique usually used – in situ hybridisa-
tion – often only identiﬁes the soma of the neuron expressing the
gene, and not their functional protein products. This is a particular
limitation for cell surface and secreted factors whose products typ-
ically function at a distance away from the cell body of the neuron,
making antibodies that work on ﬁxed neuronal tissue valuable
reagents.
The zebraﬁsh is an important model vertebrate organism for
neurobiology [4]. The ex-utero development of optically-
translucent embryos, and a range of genetic tools provide a broad
technical platform for neurobiology research [5]. One limitation of
the zebraﬁsh model, however, is the lack of high-quality antibody
reagents that work on wholemount ﬁxed tissue. While monoclonal
antibodies for use as tissue or cellular markers can easily be raised
using the ‘‘shotgun’’ method [6–8], their use is initially limited
because the identity of the antigen is at ﬁrst unknown. The paucity
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larly acute for cell surface and secreted proteins. One explanation
is that the glycans generally present on zebraﬁsh extracellular pro-
teins are highly immunogenic in mammals – which are commonly
used for raising antibodies – so that the elicited antibodies are often
not protein-speciﬁc [9]. Also, extracellular proteins are usually
modiﬁed by glycans and disulphide bonds which are not easily
mimicked by chemically-synthesized peptides, which are often
used as antigens for generating antibodies. Together, these factors
make raising antibodies against zebraﬁsh extracellular proteins a
difﬁcult process with uncertain outcomes.
Recently, we reported systematic and scalable methods for the
selection and cloning of recombinant monoclonal antibodies [10–
12]. Using a pooled immunisation approach, we demonstrated that
up to ﬁve monoclonal antibodies could be selected in parallel and
cloned into a single, convenient expression plasmid for distribution
and storage. By using the entire ectodomains of zebraﬁsh cell sur-
face proteins expressed in mammalian cells as antigens, we show
this approach is suitable for raising antibodies to neural receptors
that work in wholemount ﬁxed tissue. We also extend the func-
tionality of our antibodies by adding additional protein tags to
facilitate applications such as convenient multiplex staining.2. Materials and methods
2.1. Antigen and antibody expression and puriﬁcation
All proteins were expressed in mammalian cells as recombinant
proteins as described [11]. The extracellular regions of zebraﬁsh
cell surface and secreted proteins which were previously used in
protein interaction screens [13–15] were subcloned into a plasmid
with C-terminal rat Cd4 domains 3 + 4, an enzymatically biotiny-
latable peptide and 6-His tags [16]. Biotinylation was achieved
by cotransfecting a plasmid encoding a secreted Escherichia coli
BirA enzyme [17], and proteins puriﬁed [18] before dialysing into
PBS and storage at 4 C until use. Recombinant antibodies were
puriﬁed either using Protein G columns, or Ni-NTA Sepharose if
6-His-tagged (Invitrogen).
2.2. Antibody selection, screening and cloning
Monoclonal antibodies were raised and screened by microarray
printing as described [11]. Ampliﬁcation of both the rearranged
antibody light and heavy chain was performed using total RNA
extracted from 106 hybridoma cells and both the ampliﬁed rear-
ranged light and heavy antibody variable regions were recombined
with an overlapping ‘‘linker’’ fragment by PCR and cloned into a
single plasmid [10]. Plasmids encoding functional antibodies were
identiﬁed by colony PCR and expression selection [10,11]. The plas-
mids encoding all recombinant antibodies can be obtained from
Addgene [19].
2.3. Antibody validation by Western blotting and formalin ﬁxation by
ELISA
Western blotting was performed as described [18] using either
non-reducing or reducing conditions. Proteins were blotted onto
PVDF membranes (Amersham), blocked in 2% BSA and probed with
10 lg/ml primary antibody for 1 h at room temperature or at 4 C
overnight. ELISAs were performed essentially as described [17]
using 100 ll of puriﬁed recombinant antibody diluted in PBS/
0.2% BSA. To test antibody epitopes for formalin ﬁxation sensitiv-
ity, immobilised protein ectodomains were incubated for up to
120 min in 4% formalin and washed in PBS before the addition of
the primary antibody.2.4. Addition of alternative detection tags to recombinant antibodies
Sequences were added to the C-terminus of the IgG1 heavy
chain to permit enzymatic monobiotinylation and a 6-His-tag
(Bio-6-His) to facilitate puriﬁcation by IMAC [16], or a FLAG tag
were added using standard molecular biology procedures.
2.5. Immunohistochemistry
The animal experiments described in this study were performed
in accordance with local and national UK Home Ofﬁce regulations.
Zebraﬁsh embryos were ﬁxed with 4% formalin for 3 h at room
temperature or 4 C overnight, washed with PBT, and blocked
(PBS, 10% goat serum, 0.6% Triton and 1% DMSO) for 1 h at room
temperature. Puriﬁed recombinant antibody was diluted 1:1 in
1% goat serum, 0.6% Triton and incubated overnight at 4 C.
Embryos were washed in PBST and incubated with a secondary
anti-mouse-HRP for 2 h at room temperature. Antibodies were
detected with a TSA signal ampliﬁcation kit (Invitrogen). For dou-
ble labelling, Bio-6-His-tagged antibodies were detected with an
anti-Bio-HRP (BioRad) followed by TCA. Subsequently, the second
antigen was labelled with a FLAG-tagged antibody which was
detected with an alkaline phosphatase coupled anti-FLAG-anti-
body and visualized with Fast Red (Invitrogen).3. Results
3.1. Preparation of neural extracellular protein antigens
To maximise the probability of selecting antibodies that recog-
nise neural receptor proteins in ﬁxed tissue, we reasoned it was
important to use antigens containing epitopes found on the native
protein. Extracellular proteins are posttranslationally modiﬁed
with glycans and disulphide bonds, and so we expressed the entire
ectodomains as soluble recombinant proteins in mammalian cells
which add these modiﬁcations. We selected ten zebraﬁsh receptors
from an existing protein library [13–15] which were expressed
within the developing zebraﬁsh nervous system as determined
by in situ hybridisation [15]. The ectodomains were expressed with
C-terminal tags that enabled enzymatic biotinylation and a 6-His
tag for puriﬁcation [16]. The puriﬁed proteins typically resolved
as a single smear by SDS–PAGE centred on their expected mass,
presumably due to the presence of multiple glycoforms (Fig. 1A).
3.2. Monoclonal antibody selection, cloning and initial validation
To efﬁciently select antibodies to multiple different antigens in
parallel, we immunised mice with pools of proteins and, after
hybridoma generation and screening, antibodies of interest were
cloned into a single expression plasmid [10,12]. We found that
plasmids encoding functional antibodies were more easily identi-
ﬁed using a transfection and ELISA-based screening approach
[11] rather than the sequencing method used previously [10]; anti-
bodies were then expressed recombinantly and puriﬁed. We ﬁrst
demonstrated that all antibodies except one (anti-CD276) recogni-
sed their respective unreduced antigen whereas antibodies to
Sema4c, Bcan and Lrrc3b did not recognise reduced antigen sug-
gesting they recognise a conformational epitope (Fig. 1B). Because
these antibodies will be used to detect antigens in ﬁxed tissue, we
next quantiﬁed the rate at which the immunoreactivity of each
antibody for its antigen was lost upon formalin treatment. Eight
out of the ten antibodies were insensitive to ﬁxation, but the anti-
bodies recognising Robo1 and IgSF21b proteins did show some
sensitivity, informing us that these antibodies may lose immunore-
activity upon well-ﬁxed tissue (Fig. 1C).
Fig. 1. Most antibodies work in Western blotting and recognise epitopes that are insensitive to formalin ﬁxation. (A) Puriﬁed recombinant proteins were resolved at their
expected mass by SDS–PAGE. (B) Antibodies were tested in Western blotting against both reduced (r) and non-reduced (n) antigens as indicated. The antibodies against
Sema4c, Bcan, and Lrrc3b were sensitive to reduction of the protein suggesting they bind conformational epitopes, whereas those recognising Robo1, Igsf21a, Igsf21b, Ncam2
and Kitb recognised both reduced and non-reduced antigen. The antibody against CD276 repeatedly did not recognise antigen by Western blot. (C) The sensitivity of antibody
epitopes to formalin ﬁxation was evaluated. Antigens were ﬁxed with 4% formalin for 0, 30 or 120 min and the fractional loss of immunoreactivity was quantiﬁed by ELISA.
The majority of antibodies bound epitopes that were insensitive to formalin-ﬁxation, although immunoreactivity of anti-Igsf21b- and anti-Robo1 antibodies decreased
signiﬁcantly after 120 min. Note that the antigen and antibody analysis for Kita is not shown.
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distribution in wholemount ﬁxed tissue
We next used the antibodies to stain zebraﬁsh embryos to
determine if our approach led to the selection of antibodies that
work on wholemount ﬁxed tissue. Because a comprehensive
expression atlas for each antibody is beyond the remit of this
study, we focused on the developing zebraﬁsh brain, and compared
it to the corresponding in situ expression patterns [15]. An overall
summary of the staining patterns is provided in Supplementary
Table 1.
Three genes (ncam2, igsf21a, and brevican) are transcribed in
discrete subpopulations of neurons within the developing brain,
and the antibodies detected the corresponding protein products
in the expected pattern. ncam2 transcripts are expressed by neu-
rons giving rise to the anterior (ac) and postoptic (poc) commis-
sures at 30 h (Fig. 2A) [20]. As expected, the protein, which is
implicated in neurite outgrowth [21], was located in these com-
missures at 2.5 dpf (Fig. 2AI), and other tracts (Fig. 2AII) including
the dorso–ventral diencephalic tract (dvdt), the tracts of the pos-
terior (tpc) and postoptic (tpoc) commissures and in the retina
(Fig. 2AIII). Similarly, igsf21a is transcribed in the retina and telen-
cephalic nuclei at 2.5 dpf (Fig. 2B); correspondingly, the antibody
strongly stained the retina (arrows in Fig. 2BI), and, more weakly,
the telencephalon (asterisk in Fig. 2BI) at 3 dpf. brevican is strongly
transcribed in the ventral longitudinal tract (vlt) and discrete neu-
rons throughout the forebrain (Fig. 2C), consistent with the anti-
body staining at 5 dpf within the vlt and forebrain tracts,
including punctate staining in structures surrounding the tracts
(arrow in Fig. 2CI). These results suggested that our antibodies
could speciﬁcally stain their antigens in ﬁxed wholemount tissue.3.4. Neural receptor genes transcribed throughput the developing
brain have deﬁned patterns of protein localisation
We have previously shown that the remaining genes have dif-
fuse in situ staining pattern within the developing nervous system
(Fig. 2D–J) [15]; however, the antibodies all labelled discrete brain
structures. For example, Igsf21b is located along the supraoptic
tract (arrow in Fig. 2DI) and the prethalamus, tegmentum andthe vlt (Fig. 2DII). In the hindbrain, Igsf21b is expressed in a stripy
pattern, most likely axons leaving the vlt (Fig. 2DIII). Kitb was local-
ised in tracts and cells in the caudal brain region (Fig. 2EI), and
CD276 in the developing midbrain (Fig. 2FI). Lrrc3b was strongly
expressed on axons within the tract of the posterior commissure,
the epiphysis, discrete regions in the telencephalon, hypothalamus
and the dorsal midbrain (Fig. 2GI). Dorsal views of the optic tectum
showed Lrrc3b in neuropil-rich regions (arrow in Fig. 2GII), often
concentrated in punctate structures (asterisk in Fig. 2GIII) and more
medially along axons positioned in cell body-dense regions (arrow
in Fig. 2GIII). Robo is a guidance receptor and robo1-deﬁcient zebra-
ﬁsh have defasciculated axons in the forebrain [22], consistent
with this, anti-Robo1 labelled many forebrain commissures at
2 dpf, and some developing nuclei in the telencephalon. Robo1 is
localised in a line of cells starting in the dorsal thalamus leading
to dorsal parts of the tegmentum (arrow in Fig. 2HI). At this stage,
there was clear labelling in the posterior hypothalamus (arrow-
head in Fig. 2HI). Precursor photoreceptor cells are labelled in the
epiphysis and axons projecting posteriorly from the epithalamus
to the midbrain (asterisk in Fig. 2HI). sema4c transcripts were
expressed throughout the developing brain, but enriched in basal
parts of the fore-, mid- and hindbrain. The Sema4c protein was
detected in the anterior and postoptic commissures as well as in
telencephalic nuclei and the olfactory epithelium (Fig. 2I). In the
midbrain, Sema4c was located on the surface of cells at the dorsal
and posterior edge of the two tectal lobes. Finally, the Kita receptor
is located in neurons within the developing forebrain (arrow in
Fig. 2JI), midbrain (arrow in Fig. 2JII) and in axon-rich ventral
regions of the rostral brain (Fig. 2JIII).3.5. Neural receptor proteins are detected in discrete subcellular
localisations
Neural cell surface receptor proteins are sometimes concen-
trated within speciﬁc subcellular localisations such as synapses
or even internal vesicles, providing clues to their functional role.
Sema4c was detected at the apical site of the olfactory epithelium
(arrowhead in Fig. 3A) consistent with its documented role in
olfaction [23]. Within the neuroepithelium (arrow in Fig. 3A) and
olfactory bulb (asterisk in Fig. 3A), Sema4c was detected within
Fig. 2. Immunohistochemistry of the embryonic zebraﬁsh brain with monoclonal antibodies to neural receptors and secreted proteins. The embryo stage and transcript/
protein are indicated within each subpanel and staining patterns described within the main text. Transcript localisation is shown by wholemount in situ hybridisation as
brightﬁeld images; images of antibody staining are taken by confocal microscopy (red); nuclei are stained with DAPI in GII (green). Note that some antibody staining, for
example Igsf21a in the ventral diencephalon (BI), is outside of the optical plane. Orientation of the embryos is always anterior to the left with ventral views in A, AI, DI, II and JI;
lateral in AII, C, CI, D, DII, DIII, E, EI, G, GI, H, HI, J and JIII; and dorsal in AIII,B, BI, F, FI, GII, GIII, I and JII. Scale bars represent 100 lm in CI and EI, for all other images 50 lm.
Abbreviations used in all ﬁgures are: ac = anterior commissure, dvdt = dorso–ventral diencephalic tract, epi = epithalamus, hind = hindbrain, hypo = hypothalamus,
MHB = mid-hindbrain boundary, mid = midbrain, ob: olfactory bulb, oe = olfactory epithelium, poc = postoptic commissure, sot = supraoptic tract, tec = tectum, teg = teg-
mentum, tel = telencephalon, th = thalamus, tpc = tract of the posterior commissure, tpoc = tract of the postoptic commissure, vlt = ventral longitudinal tract, vnc = ventral
nerve cord, hpf = hours post-fertilisation, dpf = days post-fertilisation.
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Fig. 3. Antibodies detect neural receptor proteins within discrete subcellular localisations. (A) Anti-Sema4c staining in the anterior neuroepithelium. (B) Anti-Kita labels the
anterior (ac) and postoptic (poc) commissures and is also enriched at the periphery of cells (arrow). (C) Anti-Kita also stained axons of the ventral nerve cord (vnc) and the
surface of hindbrain cells. Anti-CD276 staining in the developing midbrain (D), and tectum (E). (F) Anti-Igsf21b stained axon-rich regions in the anterior forebrain where it
was often concentrated in discrete puncta (arrow). Views are anterior to the left and dorsal for A and E, lateral for B, C and F, ventral for D. Scale bars represent 100 lm in (A)
and 50 lm in (B–F).
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logue in synaptic vesicles [24]. Kita was localised along axon tracts
(arrow in Fig. 3B) and also the surface of the cell body (arrows in
Fig. 3C); notably, neurons at the telencephalon-hypothalamus bor-
der were not stained with anti-Kita (Fig. 3B). CD276 was detected
within the anterior commissure and was highly enriched on the
surface of neurons in the telencephalon and hypothalamus (arrow
in Fig. 3D). In the embryonic midbrain, we found the highest con-
centration of CD276 on the surface of posterior and lateral neurons,
often concentrated in spots around a cell body (arrow in Fig. 3E).
Finally, anti-Igsf21b stained distinct spots within the developing
forebrain (arrow in Fig. 3F).3.6. Convenient dual antibody labelling using interchangeable
recombinant antibody tags
To facilitate multiplex staining applications, we constructed
two plasmids containing C-terminal tags placed after the antibody
heavy chain that contained either a biotinylatable peptide followed
by a 6-His tag, or a FLAG tag (Fig. 4A). The regions encoding the
anti-Lrrc3b and Sema4C antibodies were subcloned into the Bio-
6-His-tagged and FLAG-tagged antibody plasmids respectively,
expressed, puriﬁed, and used to simultaneously stain the rostral
nervous system at 5 dpf (Fig. 4A). At the same site in the same
embryo, anti-Lrrc3b detected with anti-Bio-HRP (Fig. 4B) and
anti-Sema4c detected with an anti-FLAG-AP (Fig. 4C) gave distinct
expression patterns when merged (Fig. 4D). In the area of the olfac-
tory bulb, anti-Lrrc3b stained clustered puncta (arrow in Fig. 4BI),
or in similarly-sized rings (arrowhead in Fig. 4BI) whereas anti-
Sema4c stained with a grainy appearance (arrow in Fig. 4CI) with
some larger, brighter staining (arrowhead in Fig. 4CI). At the junc-
tion of the telencephalon and diencephalon, there was an increase
in the Lrrc3b-positive structures at the cellular periphery (arrow in
Fig. 4BII). Finally, Lrrc3b was again detected in subcellular puncta
at the cellular periphery (arrow in Fig. 4BIII) whereas Sema4c wasdetected in a more diffuse pattern around cell bodies (arrows in
Fig. 4CIII). Lrrc3b and Sema4c were colocalised at some sites
(arrows in Fig. 4DIII). These plasmids enable rapid and convenient
switching of protein tags on recombinant antibodies by simple
subcloning procedures, and permit the simultaneous use of these
antibodies in double or even triple antibody labelling experiments.4. Discussion
The zebraﬁsh is now a well-established model organism for
neurobiology research and has proved particularly valuable for
studying the very earliest stages of vertebrate neural development.
Despite a diverse genetic toolkit, zebraﬁsh research is hampered by
the lack of good quality antibodies that work in ﬁxed tissue. Here,
we have shown that using the entire ectodomains of receptors
expressed in mammalian cells – and therefore contain structur-
ally-critical posttranslational modiﬁcations such as glycans and
disulphide bonds – can elicit antibodies that stain native antigen
within ﬁxed embryos; indeed, all ten antibodies that we selected
to different antigens worked in this application. Antigens that lack
these modiﬁcations such as peptides are less likely to contain
native epitopes that consequently result in antibodies that are
unable to recognise the native protein. Our results suggest that
the additional resource required to express proteins in mammalian
cells is recouped by a greater probability of the antibody working
on ﬁxed tissue.
We have used this method to select a panel of ten monoclonal
antibodies against zebraﬁsh cell surface receptors expressed in
the developing nervous system. Because of its experimental conve-
nience, in situ hybridisation has been the major tool to determine
where genes are transcribed during early zebraﬁsh development
[25]. In the three instances where the gene transcripts were
localised by in situ hybridisation to identiﬁable subpopulations of
neurons (ncam2, igsf21a and brevican), the corresponding protein
gave the expected staining pattern, although typically along the
Fig. 4. The addition of different tags facilitates multiplex staining. (A) Schematics showing the addition of C-terminal Bio-6-His and FLAG tags to plasmids. The region
encoding the speciﬁc antibodies are ﬂanked by unique NotI and AscI sites facilitating antibody tag switching by subcloning. (B–D) The same 5 dpf embryo was simultaneously
stained with both the biotin-tagged anti-Lrrc3b and FLAG-tagged anti-Sema4c antibodies. The staining of anti-Lrrc3b in green (B) and anti-Sema4c in red (C), together with
the merged images (D) at the same site are shown. Staining patterns are described in the main text. Scale bars represent 50 lm.
532 N. Staudt et al. / Biochemical and Biophysical Research Communications 456 (2015) 527–533projecting axons rather than the soma of the neuron as might be
expected. Many genes encoding neural receptor proteins, however,
are expressed throughout the developing brain using standard
in situ protocols making hypotheses regarding their functional role
challenging. In the seven remaining examples where transcripts
were not localised, the antibody staining revealed the protein
product was localised to speciﬁc brain regions, and in some exam-
ples, also had a deﬁned subcellular localisation.
Recombinantly cloning antibodies has the advantage that they
can be modiﬁed with additional functional groups relatively easily.
Here, we have added biochemical tags which enable enzymatic
monobiotinylation with an oligo-histidine tag, and also a FLAG
tag. By using different tags, multiple primary and subsequently
secondary antibodies can be simultaneously added to a staining
reaction, cutting down the time required for dual labelling experi-
ments signiﬁcantly. It would be a relatively simple procedure to
add additional tags to the recombinant antibodies to facilitate dif-
ferent detection methods or other functions.
In conclusion, we have demonstrated across a panel of ten zeb-
raﬁsh neural receptors an effective method that frequently leads to
the selection of monoclonal antibodies that can be used to detect
the native protein in ﬁxed tissue. While the antibodies described
here will be useful for neurobiology research, the general approach
of expressing receptor ectodomains in mammalian cells could besimilarly applied to receptors expressed in other tissues. Finally,
the methods and antibodies described here will help to address
the paucity of validated antibodies for zebraﬁsh research.
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